Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
27 Julho 2023 - 8:00AM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia
management company focused on improving the way cardiac arrhythmias
are diagnosed and treated, announced today that its management team
will present at the 43rd Annual Canaccord Growth Conference on
Thursday, August 10, 2023 at 9:30 a.m. Eastern Time at the
InterContinental Boston Hotel in Boston, MA.
A live webcast of the presentation may be accessed by visiting
ir.acutusmedical.com. A replay of the webcast will be available
shortly after the conclusion of the presentation and will be
archived on the Company's website for 90 days.
About Acutus Medical, Inc.Acutus is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions and global partnerships,
Acutus has established a global sales presence delivering a broad
portfolio of highly differentiated electrophysiology products that
provide its customers with a complete solution for catheter-based
treatment of cardiac arrhythmias. Founded in 2011, Acutus is based
in Carlsbad, California.
Investor ContactCaroline CornerICR WestwickeD:
415-202-5678caroline.corner@westwicke.com
Media ContactRhiannon
Pickus442-232-6094Rhiannon.Pickus@acutus.com
Acutus Medical (NASDAQ:AFIB)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Acutus Medical (NASDAQ:AFIB)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024